levodopa has been researched along with Multiple Sclerosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Leitinger, G; Maurer, C; Radulović, S; Sunkara, S | 1 |
| Barbara, JM; Pace, A | 1 |
| Foster, HD; Hoffer, A | 1 |
| Butzkueven, H; Evans, AH | 1 |
| Johnson, RT; Price, DL | 1 |
| Gerber, JC; Grossman, MH; Hare, TA; Katz, L; Manyam, NV | 1 |
| Danielczyk, W | 1 |
| Moskowitz, MA; Wurtman, RJ | 1 |
| Sharpless, NS; Tabaddor, K; Wolfson, LI | 1 |
| Goto, I; Harada, M; Kira, J; Shida, N; Yamaguchi, Y | 1 |
| Hauglie-Hanssen, E; Wester, K | 1 |
2 review(s) available for levodopa and Multiple Sclerosis
| Article | Year |
|---|---|
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine | 2021 |
Catecholamines and neurologic diseases (second of two parts).
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cerebrovascular Disorders; Dopamine; Dysautonomia, Familial; Dystonia Musculorum Deformans; Hepatic Encephalopathy; Homovanillic Acid; Humans; Huntington Disease; Levodopa; Movement Disorders; Multiple Sclerosis; Nervous System Diseases; Parkinson Disease; Phenylketonurias; Seizures; Spinal Cord Injuries; Torticollis; Tourette Syndrome | 1975 |
9 other study(ies) available for levodopa and Multiple Sclerosis
| Article | Year |
|---|---|
Amantadine toxicity causing visual hallucinations.
Topics: Amantadine; Antiparkinson Agents; Female; Hallucinations; Humans; Levodopa; Multiple Sclerosis | 2023 |
The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Hallucinations; Humans; Levodopa; Multiple Sclerosis; Oxidative Stress; Parkinson Disease; Parkinson Disease, Postencephalitic; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Vitamin B Complex | 2004 |
Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
Topics: Adult; Benserazide; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Female; Gambling; Humans; Levodopa; Multiple Sclerosis; Restless Legs Syndrome | 2007 |
Chronic neurological diseases: their societal burdens and potential solutions.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Ataxia; Axons; Brain Diseases; Cerebral Cortex; Chronic Disease; Dopamine; Humans; Huntington Disease; Immunoglobulin G; Levodopa; Motor Neurons; Multiple Sclerosis; Parkinson Disease | 1980 |
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
Topics: Brain Chemistry; Cerebellar Diseases; Creatine Kinase; Dementia; Diet; Encephalitis; Epilepsy; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hypoxia; Levodopa; Multiple Sclerosis; Muscular Dystrophies; Nervous System Diseases; Parkinson Disease; Tissue Preservation | 1980 |
[Acute pharmacotoxic psychoses in patients with chronic cerebral disorders].
Topics: Aged; Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Cerebrovascular Disorders; Dementia; Digitalis Glycosides; Diuretics; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Psychoses, Substance-Induced | 1979 |
Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
Topics: Adult; Aged; Cerebral Palsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Middle Aged; Movement Disorders; Multiple Sclerosis; Parkinson Disease; Phenylacetates | 1978 |
Hyperprolactinemia in multiple sclerosis.
Topics: Adult; Bromocriptine; Dopamine; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypothalamus; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1991 |
Stereotaxic thalamotomy--experiences from the levodopa era.
Topics: Aged; Disability Evaluation; Follow-Up Studies; Humans; Levodopa; Middle Aged; Multiple Sclerosis; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Thalamus; Tremor | 1990 |